产品名称
1-甲基-L-组氨酸, ≥98.0% (TLC)
Quality Level
assay
≥98.0% (TLC)
form
powder
optical activity
[α]20/D −24±1°, c = 2% in H2O
reaction suitability
reaction type: solution phase peptide synthesis
impurities
≤5% water
mp
~240 °C (dec.) (lit.)
application(s)
peptide synthesis
SMILES string
Cn1cnc(C[C@H](N)C(O)=O)c1
InChI
1S/C7H11N3O2/c1-10-3-5(9-4-10)2-6(8)7(11)12/h3-4,6H,2,8H2,1H3,(H,11,12)/t6-/m0/s1
InChI key
BRMWTNUJHUMWMS-LURJTMIESA-N
Packaging
无底玻璃瓶。内含物装在插入的融合锥内。
Other Notes
天然的非蛋白质氨基酸;用作肌蛋白降解指标
存储类别
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
J Sjölin et al.
Metabolism: clinical and experimental, 38(1), 23-29 (1989-01-01)
The present investigation was undertaken in order to determine the release of 3-methylhistidine (3MH) from the splanchnic region and from the leg, and the contributions these make to the increase in urinary 3MH excretion in infection. Thirteen febrile patients with
P C Colombani et al.
International journal of sport nutrition, 9(2), 181-201 (1999-06-11)
A field study was performed to investigate the acute influence of a milk protein hydrolysate supplemented drink (CHO+PRO) on metabolism during and after a marathon run compared to the same drink without protein (CHO). Carbohydrate metabolites and hormones were not
3-Methylhistidine as a measure of skeletal muscle protein breakdown in human subjects: the case for its continued use.
F J Ballard et al.
Clinical science (London, England : 1979), 65(3), 209-215 (1983-09-01)
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 67520-250MG | 04061832735856 |
| 67520-50MG | 04061832735870 |